Pretreatment with oral contraceptive pills to identify poor responders that may benefit from rLH supplementation during GnRHantagonist treatment for IVF: A pilot perspective study proposal

Author：            

Publisher： Spandidos Publications

E-ISSN： 1792-1015|10|5|1692-1696

ISSN： 1792-0981

Source： Experimental and Therapeutic Medicine, Vol.10, Iss.5, 2015-01, pp. : 1692-1696

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Recombinant LH supplementation during IVF cycles with a GnRH-antagonist in estimated poor responders: A cross-matched pilot investigation of the optimal daily dose and timing

By                

Molecular Medicine Reports, Vol. 12, Iss. 3, 2015-01 ,pp. : 4219-4229

Spandidos Publications

Access to resources Recommend Favorite

Effect of pretreatment with transdermal testosterone on poor ovarian responders undergoing IVF/ICSI: A meta-analysis

By          

Experimental and Therapeutic Medicine, Vol. 8, Iss. 1, 2014-01 ,pp. : 187-194

Spandidos Publications

Access to resources Recommend Favorite

Pancreatic carcinoma-specific immunotherapy using synthesised alpha-galactosyl epitope-activated immune responders: findings from a pilot study

By Qiu Ying   Yun Mark   Xu Ming   Wang Yi   Yun Sheng  

International Journal of Clinical Oncology, Vol. 18, Iss. 4, 2013-08 ,pp. : 657-665

Springer Publishing Company

Access to resources Recommend Favorite

Treatment with an oral fluoropyrimidine, S-1, plus cisplatin in patients who failed postoperative gemcitabine treatment for pancreatic cancer: a pilot study

By Togawa Akira   Yoshitomi Hideyuki   Ito Hiroshi   Kimura Fumio   Shimizu Hiroaki   Ohtsuka Masayuki   Yoshidome Hiroyuki   Kato Atsushi   Sawada Shigeaki   Miyazaki Masaru  

International Journal of Clinical Oncology, Vol. 12, Iss. 4, 2007-08 ,pp. : 268-273

Springer Publishing Company

Access to resources Recommend Favorite

Younger patients with chronic lymphocytic leukemia benefit from rituximab treatment: A single center study in China

By            

Oncology Letters, Vol. 5, Iss. 4, 2013-01 ,pp. : 1266-1272

Spandidos Publications

Access to resources Recommend Favorite